BM
ALXN
Bridger Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-422,254
| Closed | -$66M | – | 49 |
|
|
2020
Q4 | $66M | Buy |
422,254
+43,800
| +12% | +$6.84M | 5.03% | 5 |
|
|
2020
Q3 | $43.3M | Buy |
+378,454
| New | +$43.3M | 3.46% | 11 |
|
|
2019
Q1 | – | Sell |
-200,049
| Closed | -$19.5M | – | 36 |
|
|
2018
Q4 | $19.5M | Buy |
+200,049
| New | +$19.5M | 1.62% | 25 |
|
|
2018
Q2 | – | Sell |
-92,074
| Closed | -$10.3M | – | 41 |
|
|
2018
Q1 | $10.3M | Buy |
+92,074
| New | +$10.3M | 0.62% | 35 |
|
|
2017
Q4 | – | Sell |
-555,120
| Closed | -$77.9M | – | 38 |
|
|
2017
Q3 | $77.9M | Buy |
555,120
+349,114
| +169% | +$49M | 4.66% | 4 |
|
|
2017
Q2 | $25.1M | Buy |
+206,006
| New | +$25.1M | 1.43% | 30 |
|